Capstone Investment Advisors
WST icon

Capstone Investment Advisors’s West Pharmaceutical WST Stock Holding History

Capstone Investment Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,100
Closed -$360K – 1922
2024
Q4 		$360K Sell
1,100
-1,000
-48% -$315K ﹤0.01% 1427
2024
Q3 		$630K Buy
2,100
+500
+31% +$153K ﹤0.01% 1123
2024
Q2 		$527K Sell
1,600
-100
-6% -$35.3K ﹤0.01% 1281
2024
Q1 		$673K Sell
1,700
-2,200
-56% -$814K ﹤0.01% 1392
2023
Q4 		$1.37M Sell
3,900
-900
-19% -$319K ﹤0.01% 931
2023
Q3 		$1.8M Sell
4,800
-800
-14% -$309K 0.01% 762
2023
Q2 		$2.14M Buy
5,600
+500
+10% +$179K 0.01% 623
2023
Q1 		$1.77M Buy
+5,100
New +$1.49M 0.01% 631
2022
Q2 		– Sell
-4,500
Closed -$1.85M – 2150
2022
Q1 		$1.85M Buy
4,500
+2,600
+137% +$1.02M 0.01% 1093
2021
Q4 		$891K Sell
1,900
-3,500
-65% -$1.51M ﹤0.01% 1343
2021
Q3 		$2.29M Sell
5,400
-11,600
-68% -$4.89M ﹤0.01% 1143
2021
Q2 		$6.11M Buy
17,000
+8,500
+100% +$2.81M 0.01% 670
2021
Q1 		$2.4M Buy
8,500
+7,500
+750% +$2.15M 0.01% 873
2020
Q4 		$283K Buy
+1,000
New +$281K ﹤0.01% 1392

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Capstone Investment Advisors's WST Position: Q1 2025 in Review

Capstone Investment Advisors sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 1,419 shares — an estimated $465K sold.

Capstone Investment Advisors first reported a position in WST in Q3 2016 and held it in 10 quarters. The position peaked at $2.06M in Q2 2017. 714 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Capstone Investment Advisors reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 1,419 West Pharmaceutical shares in Q1 2025, an estimated $465K.
  • Capstone Investment Advisors first reported a position in West Pharmaceutical in Q3 2016 and held it in 10 quarters.
  • Capstone Investment Advisors's West Pharmaceutical position peaked at $2.06M in Q2 2017.
  • 714 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Capstone Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.